Backed by Atlas Venture.
About the role
Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis.
What they're looking for
- Advanced scientific or clinical degree required (MD, DO, PharmD, PhD, or equivalent)
- Minimum of 10-12 years of Medical Affairs or related pharmaceutical/biotechnology experience
- Hematology/oncology experience required, expertise in myeloproliferative neoplasms (MPNs), myelofibrosis, anemia, or related hematologic disorders strongly preferred
- Experience developing and executing Medical Affairs strategies within a biotechnology or pharmaceutical environment
- Experience engaging hematology KOLs, leading advisory boards, and facilitating scientific exchange
- Experience supporting evidence generation initiatives, including RWE, HEOR, or clinical research collaborations preferred
More about this role
Join our team in a dynamic hybrid role, offering flexibility to work remotely or from our headquarters in Watertown, MA.
Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. Disc Medicine values collaboration, professional development, and scientific integrity and promotes an inclusive company culture that empowers and inspires.
The Senior Director, Medical Affairs Strategy will be responsible for developing and executing the Medical Affairs strategy for Disc Medicine’s myeloproliferative neoplasm (MPN) portfolio, with an initial focus on selcodebart (DISC-0974) in myelofibrosis-associated anemia and future pipeline opportunities including DISC-3405 in polycythemia vera (PV). This role serves as the medical affairs lead for the MPN portfolio, developing therapeutic area-specific...
Browse similar: Startup jobs